The RGS-RhoGEFs control the amplitude of YAP1 activation by serum

dc.contributor.authorLane, Brandon S.
dc.contributor.authorHeller, Brigitte
dc.contributor.authorHollenberg, Morley D.
dc.contributor.authorWells, Clark D.
dc.contributor.departmentBiochemistry and Molecular Biology, School of Medicineen_US
dc.date.accessioned2022-05-02T16:00:51Z
dc.date.available2022-05-02T16:00:51Z
dc.date.issued2021-01-27
dc.description.abstractActin-dependent mechanisms drive the nuclear translocation of Yap1 to enable its co-activation of transcription factors that induce pro-growth and survival programs. While Rho GTPases are necessary for the nuclear import of YAP1, the relevant Guanine Exchange Factors (GEFs) and GTPase Activating Proteins (GAPs) that connect this process to upstream signaling are not well defined. To this end, we measured the impact of expressing sixty-seven RhoGEFs and RhoGAPs on the YAP1 dependent activity of a TEAD element transcriptional reporter. Robust effects by all three members of the regulator of G-protein signaling (RGS) domain containing RhoGEFs (ArhGEF1, ArhGEF11 and ArhGEF12) prompted studies relating their known roles in serum signaling onto the regulation of Yap1. Under all conditions examined, ArhGEF12 preferentially mediated the activation of YAP1/TEAD by serum versus ArhGEF1 or ArhGEF11. Conversely, ArhGEF1 in multiple contexts inhibited both basal and serum elevated YAP1 activity through its GAP activity for Gα13. The sensitivity of such inhibition to cellular density and to low states of serum signaling supports that ArhGEF1 is a context dependent regulator of YAP1. Taken together, the relative activities of the RGS-RhoGEFs were found to dictate the degree to which serum signaling promotes YAP1 activity.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationLane BS, Heller B, Hollenberg MD, Wells CD. The RGS-RhoGEFs control the amplitude of YAP1 activation by serum. Sci Rep. 2021;11(1):2348. Published 2021 Jan 27. doi:10.1038/s41598-021-82027-4en_US
dc.identifier.urihttps://hdl.handle.net/1805/28812
dc.language.isoen_USen_US
dc.publisherSpringer Natureen_US
dc.relation.isversionof10.1038/s41598-021-82027-4en_US
dc.relation.journalScientific Reportsen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePMCen_US
dc.subjectRHO signallingen_US
dc.subjectActinen_US
dc.subjectBreast canceren_US
dc.subjectGrowth factor signallingen_US
dc.titleThe RGS-RhoGEFs control the amplitude of YAP1 activation by serumen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
41598_2021_Article_82027.pdf
Size:
4.34 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: